Dr Christopher M Reynolds, MD in Ypsilanti, MI - Medicare Hematology/oncology

Dr Christopher M Reynolds, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Ypsilanti, Michigan. He went to Js Weill Medical College, Cornell University and graduated in 1991 and has 33 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Iha Health Services Corporation and his current practice location is 5301 E Huron River Dr, Suite C139, Ypsilanti, Michigan. You can reach out to his office (for appointments etc.) via phone at (734) 712-1000.

Dr Christopher M Reynolds is licensed to practice in Michigan (license number 4301065161) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1710982533.

Contact Information

	Dr Christopher M Reynolds, MD
	5301 E Huron River Dr, Suite C139, Ypsilanti, MI 48197-1051
	(734) 712-1000
	(734) 712-1012

Physician's Profile

Full Name	Dr Christopher M Reynolds
Gender	Male
Speciality	Hematology/oncology
Experience	33 Years
Location	5301 E Huron River Dr, Ypsilanti, Michigan
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Christopher M Reynolds attended and graduated from Js Weill Medical College, Cornell University in 1991

NPI Data:

NPI Number: 1710982533
Provider Enumeration Date: 06/17/2005
Last Update Date: 07/14/2011

Medicare PECOS Information:

PECOS PAC ID: 1951357706
Enrollment ID: I20050324000993

Medical Identifiers

Medical identifiers for Dr Christopher M Reynolds such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1710982533	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	4301065161 (Michigan)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Saint Joseph Mercy Livingston Hospital	Howell, MI	Hospital
St Joseph Mercy Hospital	Ann arbor, MI	Hospital
St Joseph Mercy Chelsea	Chelsea, MI	Hospital
St Joe Mercy Hospital System Livonia	Livonia, MI	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Iha Health Services Corporation	2466351440	911

News Archive

Orthovita granted FDA marketing clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Orthovita, Inc. , an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Vitoss Bioactive Foam-2X Bone Graft Substitute for use as a non-structural bone void filler for use in the spine, pelvis and extremities. Orthovita expects to launch the newest addition to its bone graft substitute product line by late February or early March of 2011.

Noninvasive screening test may detect narrowing in intracranial stents

Great advances have been made in treating blockages in the arteries of the brain using angioplasty to widen the narrowed artery and a stent to hold the artery open.

Some states calling for ultrasounds to limit abortion

News outlets report on state initiatives to limit abortions by requiring an ultrasound before the procedure. "Over the last decade, ultrasound has quietly become a new front in the grinding state-by-state battle over abortion," The New York Times reports.

VA announces new ROPA program to improve radiation therapy cancer care for Veterans

The Department of Veterans Affairs today announced a new Radiation Oncology Practice Assessment (ROPA) program to leverage recent advances in information technology to improve radiation therapy cancer care for our nation's Veterans.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Christopher M Reynolds allows following entities to bill medicare on his behalf.

Entity Name	Iha Health Services Corporation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355

News Archive

Orthovita granted FDA marketing clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Noninvasive screening test may detect narrowing in intracranial stents

Great advances have been made in treating blockages in the arteries of the brain using angioplasty to widen the narrowed artery and a stent to hold the artery open.

Some states calling for ultrasounds to limit abortion

VA announces new ROPA program to improve radiation therapy cancer care for Veterans

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Christopher M Reynolds is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Christopher M Reynolds, MD 5301 E Huron River Dr, Suite C139, Ypsilanti, MI 48197-1051 Ph: (734) 712-1000	Dr Christopher M Reynolds, MD 5301 E Huron River Dr, Suite C139, Ypsilanti, MI 48197-1051 Ph: (734) 712-1000

News Archive

Orthovita granted FDA marketing clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Noninvasive screening test may detect narrowing in intracranial stents

Great advances have been made in treating blockages in the arteries of the brain using angioplasty to widen the narrowed artery and a stent to hold the artery open.

Some states calling for ultrasounds to limit abortion

VA announces new ROPA program to improve radiation therapy cancer care for Veterans

Internal Medicine Doctors in Ypsilanti, MI

Bretton Lee Schloesser, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676
Dr. Kelly Perry Apple, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 Fax: 734-712-3855
Rajiv Doddamani, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 4001, Ypsilanti, MI 48197 Phone: 734-834-4270
Dr. James Paolo Purtell, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr, Suite 2111, Ypsilanti, MI 48197 Phone: 734-712-5552
Kory Ashton Strong, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: Iha Hospital Medicine Services, 5301 E Huron River Drive, Ypsilanti, MI 48197 Phone: 734-712-8676
Michael Sanson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5361 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-1300 Fax: 734-222-3665
Dr. Stephanie Joy-kraftson Hoffman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Iha Hematology Oncology, 5303 Elliott Drive, Suite 210, Ypsilanti, MI 48197 Phone: 734-712-1000 Fax: 734-712-1012

Dr Christopher M Reynolds, MD - Medicare Hematology/oncology in Ypsilanti, MI

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Orthovita granted FDA marketing clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Noninvasive screening test may detect narrowing in intracranial stents

Some states calling for ultrasounds to limit abortion

VA announces new ROPA program to improve radiation therapy cancer care for Veterans

Medicare Reassignments

Orthovita granted FDA marketing clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Noninvasive screening test may detect narrowing in intracranial stents

Some states calling for ultrasounds to limit abortion

VA announces new ROPA program to improve radiation therapy cancer care for Veterans

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Orthovita granted FDA marketing clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Noninvasive screening test may detect narrowing in intracranial stents

Some states calling for ultrasounds to limit abortion

VA announces new ROPA program to improve radiation therapy cancer care for Veterans

Internal Medicine Doctors in Ypsilanti, MI